Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes

被引：11

作者：

Angelini, Silvia ^{[1
,2
]}

Botticelli, Andrea ^{[1
]}

Onesti, Concetta Elisa ^{[1
,2
]}

Giusti, Raffaele ^{[2
]}

Sini, Valentina ^{[1
,3
]}

Durante, Valeria ^{[1
,2
]}

Strigari, Lidia ^{[4
]}

Gentile, Giovanna ^{[5
]}

Cerbelli, Bruna ^{[6
]}

Pellegrini, Patrizia ^{[2
]}

Sgroi, Valentina ^{[1
,2
]}

Occhipinti, Mario ^{[1
,2
]}

Di Pietro, Francesca Romana ^{[1
,2
]}

Rossi, Alessandro ^{[7
]}

Simmaco, Maurizio ^{[8
]}

Mazzuca, Federica ^{[1
,2
]}

Marchetti, Paolo ^{[1
,2
,5
]}

机构：

[1] Sapienza Univ Rome, Dept Clin & Mol Med, Rome, Italy

[2] St Andrea Hosp, Dept Med Oncol, Via Grottarossa 1035, I-00189 Rome, Italy

[3] Santo Spirito Hosp, Rome, Italy

[4] Regina Elena Inst Canc Res, Lab Med Phys & Expert Syst, Rome, Italy

[5] Immacolata IDI IRCSS, Dermopat Inst, Rome, Italy

[6] Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, Rome, Italy

[7] Sapienza Univ Rome, Fac Med & Psychol, Rome, Italy

[8] Sapienza Univ Rome, Dept Neurosci Mental Hlth & Sensory Organs NESMOS, Rome, Italy

来源：

ANTICANCER RESEARCH | 2017年 / 37卷 / 05期

关键词：

Breast cancer; taxanes; polymorphisms; ABCB1; P-gp; cytochrome P450; GENETIC POLYMORPHISMS; PERIPHERAL NEUROPATHY; RANDOMIZED-TRIAL; OVARIAN-CANCER; HUMAN LIVER; PACLITAXEL; ABCB1; DOCETAXEL; EXPRESSION; CHEMOTHERAPY;

D O I：

10.21873/anticanres.11610

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Taxanes are widely used to treat breast cancer patients. Taxanes are metabolized in human liver by the cytochrome CYP3A and are substrate of ATP-binding cassette multidrug transporters ABCB1. Single-nucleotide polymorphisms (SNPs) in genes involved in taxanes' metabolism could affect the inter-individual variability in reported toxicities. Materials and Methods: In this retrospective study, 152 women, affected by breast cancer and receiving a taxane-based chemotherapy, were enrolled. A peripheral blood sample was taken for genotyping the following polymorphisms: CYP3A4* 1B (A>G), CYP3A5 * 3 (G>A) and ABCB1 (C1236T; C3435T). Results: We observed an association between ABCB1 3435 T/T and lower grade of toxicities (p=0.05). No other association were found for CYP 3A4 * 1B, 3A5*3 and ABCB1 C1236T. Conclusion: ABCB1 3435 T/T seems to be associated to lower rate of toxicity in patients receiving taxanes. Further prospective and larger studies should be performed to clarify the role of this polymorphism.

引用

页码：2633 / 2639

页数：7